First published 9/29/2026, 9:16:15 PM · Last updated 9/29/2026, 9:16:15 PM

Effectiveness of Sub-Tenon’s Bupivacaine Liposome Injectable Suspension for Postoperative Pain Control After Radioactive Plaque Placement for Ciliary Body and Choroidal Melanomas

Journal article studying the effectiveness of Sub-Tenon’s bupivacaine liposome injectable suspension for postoperative pain control after radioactive plaque placement for ciliary body and choroidal melanomas. Published by SAGE Publications on 2017-04-19, but the excerpt contains no study results or details.

Categories: public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 4/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 2/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 2/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 5/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The research topic is directly relevant to clinicians managing postoperative pain after plaque brachytherapy for ocular melanomas.

Sources

Effectiveness of Sub-Tenon’s Bupivacaine Liposome Injectable Suspension for Postoperative Pain Control After Radioactive Plaque Placement for Ciliary Body and Choroidal Melanomas

Report an issue